bivalirudin is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Bivalirudin.
Product ID | 69097-601_3cb40f48-0c9d-42f4-8d72-57b3affca50e |
NDC | 69097-601 |
Product Type | Human Prescription Drug |
Proprietary Name | bivalirudin |
Generic Name | Bivalirudin |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-07-16 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA091602 |
Labeler Name | Cipla USA Inc. |
Substance Name | BIVALIRUDIN |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-07-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA091602 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-07-16 |
Marketing Category | ANDA |
Application Number | ANDA091602 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-07-16 |
Ingredient | Strength |
---|---|
BIVALIRUDIN | 250 mg/1 |
SPL SET ID: | f7513fea-939a-4c74-b6e8-c5cb66620d1b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0409-8300 | Bivalirudin | BIVALIRUDIN |
0781-3158 | bivalirudin | bivalirudin |
0781-9158 | bivalirudin | bivalirudin |
16729-275 | Bivalirudin | Bivalirudin |
25021-405 | bivalirudin | bivalirudin |
52958-034 | Bivalirudin | Bivalirudin |
55111-652 | Bivalirudin | Bivalirudin |
55150-210 | BIVALIRUDIN | BIVALIRUDIN |
60505-6101 | Bivalirudin | bivalirudin |
63323-562 | Bivalirudin | Bivalirudin |
67457-256 | Bivalirudin | bivalirudin |
69097-601 | bivalirudin | bivalirudin |
70511-141 | bivalirudin | bivalirudin |
70860-402 | Bivalirudin | Bivalirudin |
72572-035 | bivalirudin | bivalirudin |
71288-427 | BIVALIRUDIN | BIVALIRUDIN |
0781-3447 | Angiomax | bivalirudin |
65293-001 | Angiomax | bivalirudin |